Table 2.
Average number of cells and immunophenotyping of the CD133+ and MNC groups
| Characteristics/patient | MNC groupn=30Mean (SD) | CD133+ groupn=21Mean (SD) |
|---|---|---|
| Bone marrow cell number | 2.11×109(1.62) | 2.39×109(1.42) |
| Total injected cell number | 564.63×106 (69.35) | 8.19×106 (4.26) |
| Injected cell number/site | 564.63×105 (69.35) | 8.19×105 (4.26) |
| Viability (%) | 98.53 (1.67) | 92.91 (7.66) |
| CD133+ (%) | 1.19 (1.21) | 63.69 (17.84) |
| CD34+(%) | 0.20 (0.24) | n.d. |
| CD44+(%) | 88.16 (17.57) | n.d. |
| CD31+ (%) | 42.77 (18.98) | n.d. |
| VEGFR (%) | 38.60 (26.18) | n.d. |
CD; Cluster of differentiation, MNC; Mononuclear cells, n.d.: Not determined, and VEGFR; Vascular endothelial growth factor receptor.